A disposable sensor for biofluid analysis includes: (1) a conductive film having a first major surface and a second major surface opposite to the first major surface; (2) a sensing layer disposed on the first major surface of the conductive film; and (3) an adhesive layer disposed on the second major surface of the conductive film.

A disposable sensor for biofluid analysis includes: (1) a conductive film having a first major surface and a second major surface opposite to the first major surface; (2) a sensing layer disposed on the first major surface of the conductive film; and (3) an adhesive layer disposed on the second major surface of the conductive film.

An electrode structure of a bio-signal measurement comprises electrodes adapted to be adhered on skin with an adhesive and separated from each other. A connector arrangement for an electric contact with an external electric device is on an opposite side of the electrode structure. Electric conductors are electrically connected with the electrodes and the connector arrangement. The electrode structure comprises attachable sections directly adjacent to one of the at least two electrodes, the attachable sections being adapted to be adhered on the skin. The electrode structure comprises a flexible and elastic loose section, which is free from an adherence to the skin, each of the attachable sections being located between an electrode and a loose section.

A bioelectrode sheet (100) is configured to be affixed to the skin of a subject, a drug (104b) being mixed in an adhesive layer (104) provided at a peripheral position of a conductive gel layer (103) so as to avoid the conductive gel layer (103). The drug (104b) admixed with the adhesive layer (104) can thereby be caused to penetrate the body while biological information is acquired by an electrode (102) via the conductive gel layer (103).

A bioelectrode sheet (100) is configured to be affixed to the skin of a subject, a drug (104b) being mixed in an adhesive layer (104) provided at a peripheral position of a conductive gel layer (103) so as to avoid the conductive gel layer (103). The drug (104b) admixed with the adhesive layer (104) can thereby be caused to penetrate the body while biological information is acquired by an electrode (102) via the conductive gel layer (103).

A system for heart monitoring including an electronic monitoring unit, a flexible carrier member, and a liner. The flexible carrier member includes a central void adapted to carry the electronic monitoring unit within the void and a back surface having a first connector component. The liner includes a back, adhesive surface, an opposing front surface, and a second connector component located on the front surface and adapted to secure to the first connector component of the flexible carrier member.

A body worn patient monitoring device includes a flexible substrate having a plurality of electrical connections adapted to be coupled to a skin surface to measure physiological signals. The flexible substrate is adapted to be directly and non-permanently affixed to a skin surface of a patient and configured for single patient use. A communication-computation module, removably attached to an upper surface of the flexible substrate, is configured to receive physiological signals from the flexible substrate and includes a microprocessor that is configured to process and analyze the physiological signals. A series of resistive traces screened onto the flexible substrate are configured as at least one series current-limiting resistor to protect the communication-computation module.

Systems, methods and devices for reducing noise in health monitoring including monitoring systems, methods and/or devices receiving a health signal and/or having at least one electrode or sensor for health monitoring.

Disclosed is a flexible and stretchable electronic device based on a biocompatible film. The biocompatible film is utilized as an encapsulation layer and a substrate layer of the device; a bonding layer is provided between the encapsulation layer and a functional layer; and an adhesion layer is arranged under the substrate layer. The functional layer employs a flexible and stretchable structure. Solution-based transfer printing technology is primarily used during the preparation of such a device to achieve integration of the functional layer and the flexible substrate layer. This device retains and even enhances the flexibility and stretchability structurally. Meanwhile, the biocompatibility properties thereof, such as being waterproof and air permeable, hypoallergenic, etc., allow it to work normally on the human body surface for more than 24 hours without foreign body sensation and discomfort, and thus, skin maceration, redness or other allergic reactions due to poor biocompatibility can be avoided.

Wearable devices are provided herein including wearable defibrillators, wearable devices for diagnosing symptoms associated with sleep apnea, and wearable devices for diagnosing symptoms associated with heart failure. The wearable external defibrillators can include a plurality of ECG sensing electrodes and a first defibrillator electrode pad and a second defibrillator electrode pad. The ECG sensing electrodes and the defibrillator electrode pads are configured for long term wear. Methods are also provided for using the wearable external defibrillators to analyze cardiac signals of the wearer and to provide an electrical shock if a treatable arrhythmia is detected. Methods are also disclosed for refurbishing wearable defibrillators. Methods of using wearable devices for diagnosing symptoms associated with sleep apnea and for diagnosing symptoms associated with heart failure are also provided.